9 citations
,
April 2005 in “PubMed” This study found that diffuse alopecia in female squirrel monkeys is associated with chronic telogen effluvium and appears to be predominantly age-related, potentially serving as an animal model for human diffuse alopecia.
137 citations
,
July 2004 in “Journal of The American Academy of Dermatology” This study observed that triple horizontal scalp biopsies provided a more accurate diagnosis of female pattern hair loss in women than a single horizontal biopsy, especially for those with advanced hair loss.
40 citations
,
May 2010 in “Australasian Journal of Dermatology” This study suggests that chronic telogen effluvium may be due to a reduction in the variance of anagen duration, resulting in recurrent hair shedding with minimal long-term hair volume loss.
1 citations
,
April 2021 in “International Journal of Research in Dermatology” This study found low serum ferritin and vitamin B12 levels in a significant portion of women with chronic telogen effluvium, while vitamin D deficiency was less common.
January 2012 in “Iraqi postgraduate Medical Journal” This study found that low serum ferritin levels were significantly associated with chronic telogen effluvium in adult menstruating females, suggesting that serum ferritin is a better indicator of low iron stores than hemoglobin levels in this condition.
75 citations
,
October 1996 in “Dermatologic Clinics” This review examines chronic telogen effluvium, highlighting its distinctive features and the need for reassurance about its non-progressive nature, but reports no new clinical results.
30 citations
,
November 2012 in “Anais Brasileiros De Dermatologia” This review discusses chronic telogen effluvium and diffuse alopecia areata, providing clinical and diagnostic insights, but presents no new clinical findings.
June 2023 in “Annals of the College of Medecine” This study found that childbearing women with telogen effluvium had significantly lower ferritin levels compared to healthy controls, and observed a strong inverse correlation between ferritin levels and the amount of hair shed, suggesting low iron stores may contribute to hair loss.
January 2023 in “Voennaâ medicina” This case study illustrates the successful treatment of chronic diffuse telogen effluvium in a young woman attributed to latent iron deficiency and emphasizes the importance of comprehensive assessment in similar cases.
November 2021 in “CRC Press eBooks” This article addresses the definition, diagnosis, and characteristics of telogen effluvium, a form of diffuse hair loss, but reports no new clinical results.
May 2024 in “World Journal Of Advanced Research and Reviews” This study found that females with chronic diffuse hair loss, including chronic telogen effluvium and female pattern hair loss, had significantly lower serum ferritin levels compared to controls, suggesting a strong association between decreased iron stores and hair loss.
November 2023 in “International Journal of Dermatology” In this study, researchers analyzed histopathologic findings in 32 women with chronic diffuse alopecia and found that 40.6% had androgenetic alopecia, while a diffuse variant of lichen planopilaris was diagnosed in 32.5% of cases, emphasizing the importance of histopathologic examination for accurate diagnosis.
4 citations
,
January 2005 This study found a significant association between low serum ferritin levels and chronic telogen effluvium in menstruating women, with iron treatment improving hair growth in those affected.
August 2022 in “Our Dermatology Online” This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.
June 2024 in “Al- Anbar Medical Journal” This review discusses the mechanisms, causes, and treatment options for telogen effluvium, noting acute cases often resolve by addressing causative factors, while chronic forms remain challenging to treat; recent causes include post-hair transplantation, vitamin D deficiency, and COVID-19.
3 citations
,
January 2017 in “Indian journal of health sciences and biomedical research KLEU” This study found that women with chronic diffuse hair loss had low serum ferritin levels, indicating a significant association with decreased iron stores.
17 citations
,
May 2018 in “Journal of Cosmetic Dermatology” This study reports that nonscarring diffuse hair loss in women is most common in the 21-40 age group, with low serum ferritin, vitamin B12, and vitamin D3 levels contributing to its pathogenesis.
January 2019 in “Indian Dermatology Online Journal” This study found that female pattern hair loss is the most common type of diffuse hair loss in women, with significant associations observed between chronic telogen effluvium, low iron levels, and high total iron-binding capacity.
19 citations
,
January 2015 in “Journal of Clinical and Diagnostic Research” This study found that telogen effluvium was the most common type of diffuse hair loss among women, with psychological stress and iron deficiency anemia being significant contributing factors.
3 citations
,
May 2002 in “Therapeutische Umschau” This article discusses the challenges in diagnosing and treating diffuse hair loss in women and emphasizes the importance of distinguishing between androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium, but reports no new clinical results.
In this case study, researchers reported a 37-year-old woman with androgenetic alopecia and chronic telogen effluvium experienced significant hair growth improvement after personalized integrative treatment, including caffeine application, following a four-month protocol incorporating various therapies.
January 2021 in “Journal of Clinical and Diagnostic Research” This study concluded that diffuse hair loss in women has a moderate to severe impact on their quality of life, especially among younger women and those with prolonged duration of hair loss.
January 2019 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, chronic telogen effluvium and female pattern hair loss were the most common types of non-scarring diffuse hair loss among Indian women aged 15-45, with anemia frequently present across cases.
15 citations
,
December 2000 in “Der Hautarzt” This article reviews causes, symptoms, and current treatments for chronic diffuse hair loss in women, emphasizing the need for further research into the hair cycle's molecular controls but reports no new clinical results.
October 2015 in “CRC Press eBooks” This article reviews the diagnosis and causes of different types of alopecia, presenting no new clinical findings.
6 citations
,
December 1997 in “Journal of The American Academy of Dermatology” CTE can distort results in hair growth trials, so exclude it carefully.
January 2024 in “Современные проблемы науки и образования (Modern Problems of Science and Education)” Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.
3 citations
,
May 2016 in “Dermatology Online Journal” This review discusses chronic telogen effluvium, focusing on the potential role of hormonal fluctuations and circadian control genes, and reports no new clinical findings.
45 citations
,
March 2010 in “Journal der Deutschen Dermatologischen Gesellschaft” This article discusses methods for diagnosing and managing diffuse hair loss and reports no new results; the authors emphasize systematic evaluation and the importance of psychological support.
7 citations
,
January 2015 in “Current problems in dermatology” This chapter reviews common drug-related and systemic disorder-induced alopecias, focusing on their epidemiology, causes, symptoms, diagnosis, and treatment, but reports no new findings.